Skip to main content
. 2023 Aug 10;13(8):e1352. doi: 10.1002/ctm2.1352

FIGURE 2.

FIGURE 2

AF9 expression negatively associates with CRC progression. (A) AF9 mRNA levels in tumour tissues and adjacent tissues. (B) Representative images of immunohistochemistry (IHC) using antibody against AF9 in tumour tissue and paired adjacent tissues. (C) AF9 mRNA levels in tissues from patients with different stages of CRC. (D and E) Representative images of IHC using antibody against AF9 in tissues from different stages of CRC. (F) AF9 mRNA levels in tissues from patients with or without recurrence. (G) Survival curve. CRC patients in our hospital were divided into two groups according to AF9 expression levels in CRC tissues by IHC (*p < .05, ***p < .001).